NANOSCALE VIRUS TRAP MOLECULE MARKET ANALYSIS

Market Challenges And Opportunities

Restraints

However, there are more alternate therapies under research which can compete with the viral trap molecule business. Double-stranded RNA Activated Caspase Oligomerizer (DRACO) is a nanoparticle based drug under research which is designed to detect virally infected cells and eradicate only those cells from the body. Few in-vivo and in-vitro trials have proven this drug to be very effective against different viral strains. The researchers at Charles Stark Draper Laboratory believe that this drug will be ready for clinical trials in next three to eight years.